Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis

K. Okabe; H. Toki; Y. Kimura; M. Fujii; K. Kiura; S. Moriwaki

Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis

K. Okabe, H. Toki, Y. Kimura, M. Fujii, K. Kiura, S. Moriwaki

Research output: Contribution to journal › Article › peer-review

Abstract

The correlation of surface marker phenotype with prognosis was analysed in 64 patients with non-Hodgkin's lymphoma who had been treated in Shikoku Cancer Center Hospital. B-cell lymphomas (21 cases) had significantly better prognosis than T-cell lymphomas (21 cases). The complete remission (CR) rate was 52%, and the 50% survival time was 13 months for T-cell lymphomas. All T-cell lymphoma patients died within 31 months. In B-cell lymphomas, on the other hand, the CR rate was 100%, 50% survival time was 30 months, and there were no cases of relapse in patients who had been in continuous CR for more than 2 years. About 40% of B-cell lymphomas appeared to have the potential for cure.

Original language	English
Pages (from-to)	2960-2964
Number of pages	5
Journal	Gan to kagaku ryoho. Cancer & chemotherapy
Volume	13
Issue number	10
Publication status	Published - Oct 1 1986
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following Sustainable Development Goal(s)

Fingerprint Dive into the research topics of 'Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis'. Together they form a unique fingerprint.

Cite this

@article{50371974fa5146768c709bb6fa39ba4d,

title = "Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis",

abstract = "The correlation of surface marker phenotype with prognosis was analysed in 64 patients with non-Hodgkin's lymphoma who had been treated in Shikoku Cancer Center Hospital. B-cell lymphomas (21 cases) had significantly better prognosis than T-cell lymphomas (21 cases). The complete remission (CR) rate was 52%, and the 50% survival time was 13 months for T-cell lymphomas. All T-cell lymphoma patients died within 31 months. In B-cell lymphomas, on the other hand, the CR rate was 100%, 50% survival time was 30 months, and there were no cases of relapse in patients who had been in continuous CR for more than 2 years. About 40% of B-cell lymphomas appeared to have the potential for cure.",

author = "K. Okabe and H. Toki and Y. Kimura and M. Fujii and K. Kiura and S. Moriwaki",

year = "1986",

month = oct,

day = "1",

language = "English",

volume = "13",

pages = "2960--2964",

journal = "Japanese Journal of Cancer and Chemotherapy",

issn = "0385-0684",

publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",

number = "10",

}

TY - JOUR

T1 - Non-Hodgkin's lymphoma

T2 - correlation of cell surface marker phenotype with clinical features and prognosis

AU - Okabe, K.

AU - Toki, H.

AU - Kimura, Y.

AU - Fujii, M.

AU - Kiura, K.

AU - Moriwaki, S.

PY - 1986/10/1

Y1 - 1986/10/1

N2 - The correlation of surface marker phenotype with prognosis was analysed in 64 patients with non-Hodgkin's lymphoma who had been treated in Shikoku Cancer Center Hospital. B-cell lymphomas (21 cases) had significantly better prognosis than T-cell lymphomas (21 cases). The complete remission (CR) rate was 52%, and the 50% survival time was 13 months for T-cell lymphomas. All T-cell lymphoma patients died within 31 months. In B-cell lymphomas, on the other hand, the CR rate was 100%, 50% survival time was 30 months, and there were no cases of relapse in patients who had been in continuous CR for more than 2 years. About 40% of B-cell lymphomas appeared to have the potential for cure.

AB - The correlation of surface marker phenotype with prognosis was analysed in 64 patients with non-Hodgkin's lymphoma who had been treated in Shikoku Cancer Center Hospital. B-cell lymphomas (21 cases) had significantly better prognosis than T-cell lymphomas (21 cases). The complete remission (CR) rate was 52%, and the 50% survival time was 13 months for T-cell lymphomas. All T-cell lymphoma patients died within 31 months. In B-cell lymphomas, on the other hand, the CR rate was 100%, 50% survival time was 30 months, and there were no cases of relapse in patients who had been in continuous CR for more than 2 years. About 40% of B-cell lymphomas appeared to have the potential for cure.

UR - http://www.scopus.com/inward/record.url?scp=0022792852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022792852&partnerID=8YFLogxK

M3 - Article

C2 - 3490224

AN - SCOPUS:0022792852

VL - 13

SP - 2960

EP - 2964

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 10

ER -

Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Cite this